(Q42280826)

19 October 2017

title

Idarubicin, high-dose cytarabine and etoposide for remission induction in therapy-related acute myeloid leukemia (English)

1 reference

therapy-related acute myeloid leukemia

19 October 2017

main subject

0 references

1 reference

1 reference

Philpott N

1

1 reference

19 October 2017

Mehta J

series ordinal

2

1 reference

19 October 2017

Treleaven J

series ordinal

3

1 reference

19 October 2017

Powles R

series ordinal

4

1 reference

19 October 2017

language of work or name

1 reference

1 September 1994

1 reference

19 October 2017

1 reference

19 October 2017

volume

15

1 reference

19 October 2017

issue

1-2

1 reference

19 October 2017

page(s)

127-130

1 reference

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051686

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051686

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051686

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051686

10.3109/10428199409051686

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference